Test Price
2,800 AED✅ Home Collection Available
SPTB Gene Spherocytosis Type 2 Genetic Test | DNA Labs UAE | 2,800 AED
Executive Summary & Core Metrics
Definitive Molecular Diagnosis for Hereditary Spherocytosis
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) Accredited Processing utilizing advanced NGS Technology.
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓ Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance in result interpretation by a qualified consultant.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SPTB Gene Spherocytosis Type 2 Genetic Test is a definitive next-generation sequencing (NGS) assay that analyzes the entire coding region of the SPTB gene to identify pathogenic mutations causing Hereditary Spherocytosis Type 2. This enables precise diagnosis, targeted treatment stratification, and informed family planning through cascade screening.
| Feature | Our Test (Precision USP) | Closest Alternative (Standard Panel) |
|---|---|---|
| Methodology | Comprehensive NGS with full gene coverage and copy number variant (CNV) analysis. | Targeted mutation hotspot analysis or limited single-gene Sanger sequencing. |
| Clinical Depth | Identifies novel and rare variants, with ClinVar and ACMG-guided interpretation for Spherocytosis Type 2. | May miss deep intronic or regulatory mutations; often requires a multi-gene panel without SPTB-centric analysis. |
| Turnaround Time | 3 to 4 Weeks, inclusive of comprehensive bioinformatics and clinical reporting. | Typically 5 to 8 weeks, with potential for reflex testing delays. |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) notes: "Precision in molecular genetics is non-negotiable for Hereditary Spherocytosis Type 2. This NGS assay provides high-confidence pathogenic variant detection, which is essential for accurate diagnosis and enabling cascade screening in at-risk families. It must be coupled with comprehensive pre-test and post-test genetic counseling to ensure informed decision-making."
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Patient Safety: Exclusion Criteria & Emergency Flags
- Exclusion Criteria: This test requires a documented pre-test genetic counseling session with a qualified professional. Specimen collection is not permitted without written informed consent and a completed clinical history form including a three-generation pedigree.
- Non-Invasive Logistics: For pediatric or needle-averse patients, a single drop of blood on an FTA Card is an acceptable, minimally invasive alternative to venipuncture, yielding equivalent DNA quality for NGS.
- Emergency Red Flags (Seek Immediate ER Care): If the patient experiences sudden, severe abdominal pain (splenic sequestration or gallbladder crisis), extreme pallor, dyspnea, or tachycardia during the waiting period, immediately visit the nearest emergency department.
Patient FAQ & Clinical Guidance
1. Why is this specific NGS test ordered instead of a standard anemia panel?
This provides a definitive molecular diagnosis by sequencing the entire SPTB gene, whereas standard panels only infer spherocytosis from indirect markers like osmotic fragility. These indirect markers cannot confirm the subtype or guide accurate family screening.
2. Can I use an FTA card for my infant's sample, and is it as accurate as a blood draw?
Yes, a single drop of blood on an FTA Card provides high-integrity DNA suitable for NGS, offering the same 99.9% diagnostic sensitivity as a full venous sample while ensuring a painless, non-invasive collection for your infant.
3. What happens to my genetic data according to UAE healthcare laws?
Your genetic data is strictly protected under the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. It is processed solely for this clinical purpose and is never shared without your explicit, written consent.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: DNA Labs UAE operates under the DHA Facility License No. 1143. All clinical testing and patient safety protocols strictly adhere to the Federal Decree-Law No. 4 of 2016 on Medical Liability. Data handling and patient privacy are governed by the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical & Logistical Metadata
| Test Name | SPTB Gene Spherocytosis Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks (19–28 Business Days) |
| Sample Type / Matrix | Peripheral Whole Blood, FTA Card, or Isolated Genomic DNA |
| Methodology Used | Next-Generation Sequencing (NGS), Full Gene Coverage & Copy Number Variant (CNV) Analysis |
| ICD-10-CM Code | D58.0 |
| LOINC Code | 81316-6 |
| DHA Facility License & Laboratory Address Invariants | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians